169 related articles for article (PubMed ID: 26892683)
1. Expression of DNA methyltransferases 1 and 3B correlates with EZH2 and this 3-marker epigenetic signature predicts outcome in glioblastomas.
Purkait S; Sharma V; Kumar A; Pathak P; Mallick S; Jha P; Sharma MC; Suri V; Julka PK; Suri A; Sharma BS; Sarkar C
Exp Mol Pathol; 2016 Apr; 100(2):312-20. PubMed ID: 26892683
[TBL] [Abstract][Full Text] [Related]
2. Methyltransferase expression and tumor suppressor gene methylation in sporadic and familial colorectal cancer.
Joensuu EI; Nieminen TT; Lotsari JE; Pavicic W; Abdel-Rahman WM; Peltomäki P
Genes Chromosomes Cancer; 2015 Dec; 54(12):776-87. PubMed ID: 26305882
[TBL] [Abstract][Full Text] [Related]
3. DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression.
Ning X; Shi Z; Liu X; Zhang A; Han L; Jiang K; Kang C; Zhang Q
Cancer Lett; 2015 Apr; 359(2):198-205. PubMed ID: 25595591
[TBL] [Abstract][Full Text] [Related]
4. Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer.
Hoffmann MJ; Engers R; Florl AR; Otte AP; Muller M; Schulz WA
Cancer Biol Ther; 2007 Sep; 6(9):1403-12. PubMed ID: 18637271
[TBL] [Abstract][Full Text] [Related]
5. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.
Girault I; Tozlu S; Lidereau R; Bièche I
Clin Cancer Res; 2003 Oct; 9(12):4415-22. PubMed ID: 14555514
[TBL] [Abstract][Full Text] [Related]
6. EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma.
Zhang J; Chen L; Han L; Shi Z; Zhang J; Pu P; Kang C
Cancer Lett; 2015 Jan; 356(2 Pt B):929-36. PubMed ID: 25444902
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance and prognostic value of DNA methyltransferase 1, 3a, and 3b expressions in sporadic epithelial ovarian cancer.
Bai X; Song Z; Fu Y; Yu Z; Zhao L; Zhao H; Yao W; Huang D; Mi X; Wang E; Zheng Z; Wei M
PLoS One; 2012; 7(6):e40024. PubMed ID: 22768205
[TBL] [Abstract][Full Text] [Related]
8. DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function.
Jin B; Tao Q; Peng J; Soo HM; Wu W; Ying J; Fields CR; Delmas AL; Liu X; Qiu J; Robertson KD
Hum Mol Genet; 2008 Mar; 17(5):690-709. PubMed ID: 18029387
[TBL] [Abstract][Full Text] [Related]
9. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
Oh BK; Kim H; Park HJ; Shim YH; Choi J; Park C; Park YN
Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of polycomb group protein expression in advanced gastric cancer.
Lee H; Yoon SO; Jeong WY; Kim HK; Kim A; Kim BH
Hum Pathol; 2012 Oct; 43(10):1704-10. PubMed ID: 22520951
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-144 suppresses tumorigenesis and tumor progression of astrocytoma by targeting EZH2.
Lin L; Zheng Y; Tu Y; Wang Z; Liu H; Lu X; Xu L; Yuan J
Hum Pathol; 2015 Jul; 46(7):971-80. PubMed ID: 25907866
[TBL] [Abstract][Full Text] [Related]
12. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.
Vinchure OS; Sharma V; Tabasum S; Ghosh S; Singh RP; Sarkar C; Kulshreshtha R
Int J Cancer; 2019 Sep; 145(5):1254-1269. PubMed ID: 31008529
[TBL] [Abstract][Full Text] [Related]
13. Anxiety is associated with higher levels of global DNA methylation and altered expression of epigenetic and interleukin-6 genes.
Murphy TM; O'Donovan A; Mullins N; O'Farrelly C; McCann A; Malone K
Psychiatr Genet; 2015 Apr; 25(2):71-8. PubMed ID: 25350786
[TBL] [Abstract][Full Text] [Related]
14. Expression and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in tamoxifen-treated breast cancer patients.
Jahangiri R; Jamialahmadi K; Gharib M; Emami Razavi A; Mosaffa F
Gene; 2019 Feb; 685():24-31. PubMed ID: 30359738
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas.
Zhang X; Dong Y; Ti H; Zhao J; Wang Y; Li T; Zhang B
Hum Pathol; 2013 Nov; 44(11):2571-80. PubMed ID: 24071015
[TBL] [Abstract][Full Text] [Related]
16. SIRT1 affects DNA methylation of polycomb group protein target genes, a hotspot of the epigenetic shift observed in ageing.
Wakeling LA; Ions LJ; Escolme SM; Cockell SJ; Su T; Dey M; Hampton EV; Jenkins G; Wainwright LJ; McKay JA; Ford D
Hum Genomics; 2015 Jun; 9(1):14. PubMed ID: 26104761
[TBL] [Abstract][Full Text] [Related]
17. Expression of the enhancer of zeste homolog 2 in biopsy specimen predicts chemoresistance and survival in advanced non-small cell lung cancer receiving first-line platinum-based chemotherapy.
Xu C; Hao K; Hu H; Sheng Z; Yan J; Wang Q; Yu L
Lung Cancer; 2014 Nov; 86(2):268-73. PubMed ID: 25262426
[TBL] [Abstract][Full Text] [Related]
18. Activation of SAPK/JNK mediated the inhibition and reciprocal interaction of DNA methyltransferase 1 and EZH2 by ursolic acid in human lung cancer cells.
Wu J; Zhao S; Tang Q; Zheng F; Chen Y; Yang L; Yang X; Li L; Wu W; Hann SS
J Exp Clin Cancer Res; 2015 Sep; 34(1):99. PubMed ID: 26362062
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of epigenetic modifiers EZH2, H3K27me3, and DNA methyltransferases in meningiomas - prognostic biomarkers for routine practice.
Samal S; Patnaik A; Sahu F; Purkait S
Folia Neuropathol; 2020; 58(2):133-142. PubMed ID: 32729292
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of X-linked cancer/germline antigen genes by DNMT1 and DNMT3b.
James SR; Link PA; Karpf AR
Oncogene; 2006 Nov; 25(52):6975-85. PubMed ID: 16715135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
